These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29671834)

  • 1. Using Peptidomimetics and Constrained Peptides as Valuable Tools for Inhibiting Protein⁻Protein Interactions.
    Robertson NS; Spring DR
    Molecules; 2018 Apr; 23(4):. PubMed ID: 29671834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Review of Stapled Peptides and Small Molecules to Inhibit Protein-Protein Interactions in Cancer.
    Iyer VV
    Curr Med Chem; 2016; 23(27):3025-3043. PubMed ID: 27356541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides and peptidomimetics as inhibitors of protein-protein interactions involving β-sheet secondary structures.
    Laxio Arenas J; Kaffy J; Ongeri S
    Curr Opin Chem Biol; 2019 Oct; 52():157-167. PubMed ID: 31590141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidomimetics Targeting Protein-Protein Interactions for Therapeutic Development.
    Zhang G; Andersen J; Gerona-Navarro G
    Protein Pept Lett; 2018; 25(12):1076-1089. PubMed ID: 30381055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of stapled helical peptides to perturb the Cdt1-Mcm6 interaction.
    Lee JP; Liu C; Li T; Zhu G; Li X
    J Pept Sci; 2015 Jul; 21(7):593-8. PubMed ID: 25921752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Peptides to Peptidomimetics: A Strategy Based on the Structural Features of Cyclopropane.
    Mizuno A; Matsui K; Shuto S
    Chemistry; 2017 Oct; 23(58):14394-14409. PubMed ID: 28632330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic Peptides for Protein-Protein Interaction Targets: Applications to Human Disease.
    Rubin S; Qvit N
    Crit Rev Eukaryot Gene Expr; 2016; 26(3):199-221. PubMed ID: 27650985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macropinocytosis as a Key Determinant of Peptidomimetic Uptake in Cancer Cells.
    Yoo DY; Barros SA; Brown GC; Rabot C; Bar-Sagi D; Arora PS
    J Am Chem Soc; 2020 Aug; 142(34):14461-14471. PubMed ID: 32786217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constraining cyclic peptides to mimic protein structure motifs.
    Hill TA; Shepherd NE; Diness F; Fairlie DP
    Angew Chem Int Ed Engl; 2014 Nov; 53(48):13020-41. PubMed ID: 25287434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution in non-peptide α-helix mimetics on the road to effective protein-protein interaction modulators.
    Algar S; Martín-Martínez M; González-Muñiz R
    Eur J Med Chem; 2021 Feb; 211():113015. PubMed ID: 33423841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tailoring peptidomimetics for targeting protein-protein interactions.
    Akram ON; DeGraff DJ; Sheehan JH; Tilley WD; Matusik RJ; Ahn JM; Raj GV
    Mol Cancer Res; 2014 Jul; 12(7):967-78. PubMed ID: 24642350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomimetics as protein-inspired scaffolds with defined tertiary folding patterns.
    Horne WS; Grossmann TN
    Nat Chem; 2020 Apr; 12(4):331-337. PubMed ID: 32029906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational modulator design by exploitation of protein-protein complex structures.
    Wichapong K; Poelman H; Ercig B; Hrdinova J; Liu X; Lutgens E; Nicolaes GA
    Future Med Chem; 2019 May; 11(9):1015-1033. PubMed ID: 31141413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptides and peptidomimetics as regulators of protein-protein interactions.
    Cunningham AD; Qvit N; Mochly-Rosen D
    Curr Opin Struct Biol; 2017 Jun; 44():59-66. PubMed ID: 28063303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Design of Inhibitors of Protein-Protein Interactions: Mimicking Peptide Binding Epitopes.
    Pelay-Gimeno M; Glas A; Koch O; Grossmann TN
    Angew Chem Int Ed Engl; 2015 Jul; 54(31):8896-927. PubMed ID: 26119925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics.
    Liskamp RM; Rijkers DT; Kruijtzer JA; Kemmink J
    Chembiochem; 2011 Jul; 12(11):1626-53. PubMed ID: 21751324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Druggability assessment of protein-protein interfaces.
    Wanner J; Fry DC; Peng Z; Roberts J
    Future Med Chem; 2011 Dec; 3(16):2021-38. PubMed ID: 22098351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Designing Peptidomimetics.
    Perez JJ
    Curr Top Med Chem; 2018; 18(7):566-590. PubMed ID: 29788887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPII Helical Peptidomimetics Templated by Cation-π Interactions.
    Craven TW; Bonneau R; Kirshenbaum K
    Chembiochem; 2016 Oct; 17(19):1824-1828. PubMed ID: 27539882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptidomimetics via modifications of amino acids and peptide bonds.
    Avan I; Hall CD; Katritzky AR
    Chem Soc Rev; 2014 May; 43(10):3575-94. PubMed ID: 24626261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.